New York · 2025 Regular Session · Bill
S 1720: Establishes an awareness campaign on the use of hormone replacement therapy in treating the symptoms of perimenopause and menopause
Vetoed Official data
- Introduced
- In committee
- Passed one chamber
- Passed both chambers
- Enacted
- Vetoed
Last official action: ·Record last updated:
Plain-language summary
S 1720 is a bill introduced in the New York Senate on January 13, 2025. According to its official title, it concerns: Establishes an awareness campaign on the use of hormone replacement therapy in treating the symptoms of perimenopause and menopause. Primary sponsor: Roxanne Persaud (Democratic). It lists 2 additional sponsors. Most recent recorded action (October 16, 2025): VETOED MEMO.47.
Generated automatically from the official title, sponsor list, and status record only. It does not characterize the bill’s purpose or effects. How summaries are written
Official summary
Abstract published by the legislature (via Open States). Text as published by the legislature; reproduced verbatim.
Establishes an awareness campaign on the use of hormone replacement therapy in treating the symptoms of perimenopause and menopause.
Sponsors
Sponsors by party (alphabetical): Democratic 2 · Democratic/Working Families 1
| Name | Role | Party | Chamber | District |
|---|---|---|---|---|
| Roxanne Persaud | Primary sponsor | Democratic | Senate | 19 |
| Pete Harckham | Co-sponsor | Democratic/Working Families | Senate | 40 |
| John Liu | Co-sponsor | Democratic | Senate | 16 |
“Support” is shown only as formal sponsorship recorded by the legislature. Roll-call votes are available on the official bill page.
Recent official actions
- VETOED MEMO.47
- DELIVERED TO GOVERNOR
- RETURNED TO SENATE
- PASSED ASSEMBLY
- ORDERED TO THIRD READING RULES CAL.379
- SUBSTITUTED FOR A2698
- REFERRED TO HEALTH
- DELIVERED TO ASSEMBLY
- PASSED SENATE
- ORDERED TO THIRD READING CAL.106
- COMMITTEE DISCHARGED AND COMMITTED TO RULES
- REFERRED TO WOMEN'S ISSUES